Results 131 to 140 of about 27,278 (203)

Food Intake According to Clock Gene Polymorphisms: A Systematic Review

The FASEB Journal, Volume 39, Issue 15, 15 August 2025.
The study used PubMed, Embase, and Cochrane databases, screening with Rayyan QCRY. Ten studies were included, totaling 12 115 adults (40.8 ± 8.6 years, mostly women). SNPs analyzed were CLOCK (rs1801260, rs4580704, rs3749474) and Cry1/Cry2 (rs2287161, rs11605924). No studies examined Bmal, PER, Rev‐erb, or ROR SNPs. Only Rahati et al.
Laís Teixeira Campos, Polimar Ferreira Fonseca, Daniela Mayumi Usuda Prado Rocha, Josefina Bressan, Ana Claudia Pelissari Kravchychyn, Helen Hermana Miranda Hermsdorff   +5 more
wiley   +1 more source

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

Annals of Clinical and Translational Neurology, Volume 12, Issue 8, Page 1595-1607, August 2025.
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo, Gianmarco Abbadessa, Silvia Garavelli, Clorinda Fusco, Claudia Russo, Francesco Perna, Federica Garziano, Claudia La Rocca, Maria Mottola, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Luca Spiezia, Alessia Castiello, Roberta Lanzillo, Vincenzo Brescia Morra, Claudio Procaccini, Paola de Candia, Giuseppe Matarese   +19 more
wiley   +1 more source

Comprehensive Characterization of Bihormonal Cells and Endocrine Cell Lineages in Mammalian Pancreatic Islets

Advanced Science, Volume 12, Issue 30, August 14, 2025.
This study integrates dual‐reporter genetics, imaging flow cytometry, and single‐cell sequencing to characterize rare bihormonal cells in mouse and human pancreatic islets. Gcg⁺Ins⁺ cells resemble α‐cells rather than transitional states. Cross‐species gene network analysis refines islet cell taxonomy and reveals human‐specific δ‐cell subtypes ...
Xin‐Xin Yu, Peng Peng, Yi‐Ning Wang, Mao‐Yang He, Shuang He, Chen‐Tao Jin, Liu Yang, Xi Wang, Jia‐Xi Zheng, Jie Gao, Cheng‐Ran Xu   +10 more
wiley   +1 more source

Ghrelin is essential for lowering blood pressure during torpor

Frontiers in Endocrinology
IntroductionDaily torpor is an active hypothermic phenomenon that is observed in some mammals and birds during fasting. A decrease in blood pressure has also been observed in torpor; however, there remains a lack of knowledge of the underlying mechanism.
Kazuma Matsui, Takanori Ida, Kanae Oishi, Masayasu Kojima, Takahiro Sato   +4 more
doaj   +1 more source

Bidirectional Relationship Between Dental Diseases and Sleep Disturbances in Pediatric Patients

Clinical and Experimental Dental Research, Volume 11, Issue 4, August 2025.
ABSTRACT Background Certain dental diseases in pediatric patients may disturb their sleep, affect their oral health‐related quality of life, and result in a negative influence on cognition and behavior. On the other hand, sleep disturbances may also increase the risk or participate in development and progression of dental diseases.
Yaqiong Zhang, Wenqi Yang, Qi Sun, Fangkai Han, Minjun Dong   +4 more
wiley   +1 more source

Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024

Drug Testing and Analysis, Volume 17, Issue 8, Page 1417-1442, August 2025.
Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario  Thevis, Tiia  Kuuranne, Hans  Geyer   +2 more
wiley   +1 more source

Intermittent Fasting and Hormonal Regulation: Pathways to Improved Metabolic Health

Food Science &Nutrition, Volume 13, Issue 8, August 2025.
Intermittent fasting regulates key hormonal pathways affecting metabolic health. Intermittent fasting improves insulin sensitivity and β‐cell response. Intermittent fasting preserves circadian rhythm by advancing melatonin secretion. ABSTRACT Intermittent fasting (IF), a temporal dietary pattern, has garnered interest in improving anthropometric and ...
Wijdan Shkorfu, Abdulmannan Fadel, Mohammed Hamsho, Yazan Ranneh, Hafiz Muhammad Shahbaz   +4 more
wiley   +1 more source

Yerba Mate (Ilex paraguariensis St. Hill.) Tea May Have Cardiometabolic Beneficial Effects in Healthy and At‐Risk Subjects: A Randomized, Controlled, Blind, Crossover Trial in Nonhabitual Consumers

Molecular Nutrition &Food Research, Volume 69, Issue 15, August 2025.
Yerba mate intake shows cardiometabolic beneficial effects decreasing blood pressure, blood lipids, inflammatory biomarkers and body fat in healthy and hypercholesterolemic non‐habitual consumers. ABSTRACT Yerba mate has been reported to have antihypertensive, hypocholesterolemic, antidiabetic, or antiobesity properties.
Laura Bravo, Sara Martínez‐López, Jose Luis Sierra‐Cinos, Raquel Mateos, Beatriz Sarriá   +4 more
wiley   +1 more source

Resveratrol Prevents Weight Gain, Counteracts Visceral Adipose Tissue Dysfunction, and Improves Hypothalamic Leptin Sensitivity in Diet‐Induced Obese Rats

Molecular Nutrition &Food Research, Volume 69, Issue 15, August 2025.
Resveratrol improves hypothalamic leptin sensitivity and prevents body weight gain in obese animals, while mitigating adipocyte hypertrophy and promoting adipocyte hyperplasia in the retroperitoneal fat depot. ABSTRACT In obesity, increased adipocyte size is associated with metabolic complications, while elevated adipocyte numbers are considered a ...
Maria Ibars‐Serra, Aïda Pascual‐Serrano, Andrea Ardid‐Ruiz, Núria Doladé, Sonia Aguilar‐González, Julieta Cirasino, Begoña Muguerza, Manuel Suárez, Jaap Keijer, Anna Arola‐Arnal, Gerard Aragonès   +10 more
wiley   +1 more source

Long‐acting PYY3−36 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies

Obesity, Volume 33, Issue 8, Page 1457-1474, August 2025.
Abstract Objective The hormone peptide YY (PYY; cleaved into Y2‐selective form PYY3‐36) is an attractive candidate for use as a complementary pharmacotherapy for obesity along with glucagon‐like peptide‐1 (GLP‐1) receptor agonists. This series of studies investigated a novel long‐acting PYY3‐36 analogue (PYY1875) alone and as an add‐on to semaglutide ...
Birgitte S. Wulff, Adam Paul Chambers, Cynthia Karenina Osorto Contreras, Katrine Kirkeby, Anders Rasmussen Rinnov, Riia K. Sustarsic, Søren Østergaard, John E. Laabs, Patrick M. O'Neil   +8 more
wiley   +1 more source